BAILEY EVAN PRESCOTT enters APPLIED THERAPEUTICS, INC. with 541.67K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/17/2025ACC: 0000950170-25-087354
Officer· Chief Medical Officer
Since Dec 2025
541.67K
Baseline shares
100% direct
541.67K
Direct ownership
1 position
24.41K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned541.67K
Total
541.67K direct541.67K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 541.67K | Direct |
| Total | 541.67K | 541.67K direct |
Derivative Holdings2
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
4.88K
Shares owned
N/A
Exercise price
1.50
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
19.53K
Shares owned
N/A
Exercise price
1.50
Expiration
—
Exercise window
—
Total
Underlying
24.41K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 1.50 | — | — | 4.88K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 1.50 | — | — | 19.53K | N/A |
| Total | 24.41K | 0.00 | ||||